| 发明名称 |
Selective NR2B Antagonists |
| 摘要 |
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, antagonists of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.
|
| 申请公布号 |
US2013085138(A1) |
申请公布日期 |
2013.04.04 |
| 申请号 |
US201213627130 |
申请日期 |
2012.09.26 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY;BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
KING DALTON;OLSON RICHARD E.;MACOR JOHN E.;ISLAM IMADUL;THANGATHIRUPATHY SRINIVASAN;WARRIER JAYAKUMAR SANKARA |
| 分类号 |
A61K31/4709;A61K31/4245;A61K31/498;A61K31/501;A61K31/506;A61K31/519;A61K31/538;A61P25/16;A61P25/24;A61P25/28;A61P29/00;C07D413/12;C07D413/14;C07D487/04 |
主分类号 |
A61K31/4709 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
